Adam Berger
About Adam Berger
Adam Berger serves as the Director of the Division of Clinical and Healthcare Research Policy at the National Institutes of Health, where he has worked since 2018. He has a strong background in personalized medicine and has received multiple awards for his research contributions.
Work at National Institutes of Health
Adam Berger serves as the Director of the Division of Clinical and Healthcare Research Policy at the National Institutes of Health (NIH). He has held this position since 2018, contributing to the development of policies that influence clinical and healthcare research. His role involves facilitating discussions and reports on critical topics, including Genome-Based Diagnostics and the integration of genomic data into clinical practices. Berger's work supports the NIH's mission to improve health through research and innovation.
Education and Expertise
Adam Berger earned his Doctor of Philosophy (Ph.D.) in Biochemistry, Cell and Developmental Biology from Emory University, where he studied from 1999 to 2004. He also holds a Bachelor of Science (B.S.) in Molecular Genetics from The Ohio State University, completed from 1993 to 1997. His educational background provides a strong foundation for his expertise in clinical research and healthcare policy.
Background
Before joining the NIH, Adam Berger worked at the FDA as a Senior Staff Fellow in Personalized Medicine from 2015 to 2018. He also served as a Senior Program Officer at the Institute of Medicine from 2009 to 2015. His experience in these roles has equipped him with a comprehensive understanding of regulatory and policy aspects of healthcare and research.
Achievements
Adam Berger is a recipient of the NIH Fellows Award for Research Excellence and the Ruth L. Kirschstein National Research Service Award. These awards recognize his contributions to research and policy in the field of healthcare. His work has facilitated important public policy discussions on the use of genomic information in clinical settings.
Postdoctoral Training
Adam Berger completed his postdoctoral training at the National Cancer Institute of the NIH. This training further developed his research skills and knowledge in cancer biology, contributing to his expertise in clinical and healthcare research policy.